// App-Quantinova.ai

1510 : Conflicting interpretation of Genetic Variants and Cancerer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing (PROMPT)

Researchers

Presenter

  • Judith Balmana

Principal Investigators

  • Laura Digiovanni

  • Pragna Gaddam

  • Michael Francis Walsh

  • Judy Ellen Garber

  • Fergus J. Couch

  • Kenneth Offit

  • Mark E. Robson

  • Susan M. Domchek

Medical Centers

  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain

  • University of Pennsylvania, Philadelphia, PA

  • Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Dana-Farber Cancer Institute, Boston, MA

  • Mayo Clinic, Rochester, MN

  • University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Locations

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved